The current Medicare payment model for oxygen equipment and services limits access and patient choice for this critically needed care, causing undue stress on patients and caregivers while increasing the risk of hospitalizations and other costly clinical interventions.

On April 10, 2025, legislation to remove all oxygen equipment from Medicare’s flawed DMEPOS Competitive Bidding Program and to establish a separate payment rate for liquid oxygen was introduced in both chambers of Congress.  

S. 1406 and H.R. 2902, the Supplemental Oxygen Access Reform Act of 2025 (SOAR Act), allow liquid oxygen patients to receive the most appropriate care for their condition by establishing a base reimbursement rate for all liquid oxygen equipment as well as an add-on payment for individuals who require very high flow rates. The bills also streamline documentation and deter criminal fraud activity by establishing template-based national standardized documentation requirements.

Please send a letter to your U.S. Senators and Representative today asking them to co-sponsor the SOAR Act and enact comprehensive supplemental oxygen reform this year.  You are encouraged to add your own story to the letter to reflect your experience supporting patients who use oxygen products and how this legislation would help you in this important work.

Find additional messaging and resources on the SOAR Act and other legislative initiatives on our 2026 Advocacy Priorities page.  Thank you for your advocacy in support of high-quality home-based care.